Collaborate with your peers at the Neuroimmunology Drug Development Summit (NIDD), the first industry-focused networking forum to learn and share insight on how to successfully target chronic neuroinflammation as a universal therapeutic for various neurological diseases. With an emphasis on neurodegeneration, NIDD will provide a discussion-led platform for you to discover the best strategies and most innovative technologies to aid your future neuroimmunological research. Join the 70+ world class experts from AbbVie, Sanofi, Denali, Alector and Eisai to successfully guide the development of clinically efficacious therapeutics. Time: 8:00 am - 5:00 pm Venue details: Hyatt Regency Boston, 1 Avenue de Lafayette, Boston, 02111, USA